戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              HT also attenuated the enhancement of the BP response in
2                                              HT decreased (p < 0.05) the antiproliferative activity o
3                                              HT pretreatment of sewage sludge had a weak effect on th
4                                              HT-DBP is a microscopy-based, single-cell resolution ass
5                                              HT-DBP requires only 24 hours of ex vivo culture, which
6                                              HT-induced indels occur disproportionately in nucleosome
7 tion experiments on FAP-transfected HT-1080 (HT-1080-FAP) or on mouse FAP-expressing (HEK-muFAP) and
8 ew effective procedures for reduction of T-2/HT-2 toxin levels is needed.
9                                            5-HT(2A)R agonist-induced head-twitch behavior was also au
10                                            5-HT(2A,) a G-protein coupled receptor, is widely expresse
11                                            5-HT(3) receptors are pentameric ligand-gated ion channels
12                                            5-HT(7) receptors in their inactive state associate with G
13                                            5-HT-ir neurons were also observed within the vocal motor
14                              Serotonin 1A (5-HT(1A)) autoreceptors regulate brain-wide serotonin neur
15 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT(1A)) receptors, may represent a new class of psychotr
16 854944) was to assess D(2)/D(3), 5-HT(1A), 5-HT(2A) and serotonin transporter (SERT) occupancies of b
17 e dependent manner, while binding to D(3), 5-HT(1A) receptors and SERT was not detectable with the ra
18 udy (NCT01854944) was to assess D(2)/D(3), 5-HT(1A), 5-HT(2A) and serotonin transporter (SERT) occupa
19 s of the homomeric 5-hydroxytryptamine 3A (5-HT(3A)) serotonin receptor for 15 to 20 mus to demonstra
20 at antagonizing serotonin (5-HT) type 3AB (5-HT(3AB)) receptors in brain areas involved in mood regul
21 hy volunteers were randomly allocated to a 5-HT depletion (N = 24), DA depletion (N = 24), or placebo
22  Compound 12 (CTW0415) was discovered as a 5-HT(2C)R PAM with improved pharmacokinetics and reduced o
23 timulation of beta-cells were blocked by a 5-HT(3)R antagonist and were enhanced by increasing seroto
24 erted more rapidly to baseline following a 5-HT-challenge.
25                 We evaluated whether acute 5-HT(4)R activation in glutamatergic axon terminals arisin
26                In the absence of agonists, 5-HT(2A)R was primarily localized within intracellular com
27 ts, glutamate acting at AMPA receptors and 5-HT acting at 5-HT(2A) receptors.
28 r pathways regenerated into the graft, and 5-HT(+) neurons within graft and host brainstem neurons we
29  the 5-HT(2A) (5-hydroxytryptamine 2A) and 5-HT(1A) (5-hydroxytryptamine 1A) receptors.
30 ated in vivo binding to D(2) receptors and 5-HT(2A) receptors at steady state after 10 days of daily
31  the two receptors in 5-HT(2A)/mGlu(2) and 5-HT(2A)/mGlu(2)/Gqo5 cells.
32 A)-, mGlu(2)/Gqo5-, 5-HT(2A)/mGlu(2)-, and 5-HT(2A)/mGlu(2)/Gqo5-expressing HEK293 cells using a Ca(2
33           The inhibition of 5-HT(3A)Rs and 5-HT(3AB)Rs was non-use dependent and voltage independent,
34  of serotonin receptors, with 5-HT(2B) and 5-HT(7) expression restricted to M-CSF-primed monocyte-der
35       Na(V)1.8(-/-) impaired histamine and 5-HT-induced scratching while Na(V)1.9 was involved in itc
36 op of contractions induced by KCl, ACh and 5-HT.
37 Negligible occupancy (<5%) was observed at 5-HT(1A) and SERT at 4 mg/day.
38 cting at AMPA receptors and 5-HT acting at 5-HT(2A) receptors.
39                              Behaviorally, 5-HT depleted subjects demonstrated impaired social reward
40 CD is required for the interaction between 5-HT(3A) and the chaperone protein resistance to inhibitor
41 sponses in 5-HT(2A)/mGlu(2) cells and both 5-HT- and Glu-induced responses in 5-HT(2A)/mGlu(2)/Gqo5 c
42 teric regulation of ion gating elements by 5-HT binding is indicative of a preactive state, which pro
43 ase was attenuated, suggesting blunted CeA 5-HT sensitivity, which partially recovered in protracted
44  and unravels the vulnerability of the CeA 5-HT system to chronic alcohol and protracted withdrawal.S
45  firing rate of DRN 5-HT neurons, cerebral 5-HT depletion, and optogenetic activation and silencing w
46 addition, we comprehensively characterized 5-HT-immunoreactive (-ir) innervation throughout the brain
47  vocal midbrain nuclei showed considerable 5-HT-ir innervation, as did thalamic and hindbrain auditor
48 pairment, but not increased frontal cortex 5-HT(2A)R density or psychedelic-induced head-twitch behav
49     It may thus be the case that decreased 5-HT levels contribute to social learning deficits in depr
50 These changes presumably lead to decreased 5-HT synthesis and/or increased 5-HT reuptake, thereby red
51 onal knockout male mice supports deficient 5-HT transmission underlying depression-related phenotypes
52      Expanding upon our recently described 5-HT(2C)R-positive allosteric modulators (PAMs) based on t
53 , in vivo recordings of firing rate of DRN 5-HT neurons, cerebral 5-HT depletion, and optogenetic act
54 sure and protracted withdrawal dysregulate 5-HT signaling in the CeA.
55 ) allosteric site to potentiate endogenous 5-HT tone may provide novel therapeutics to alleviate the
56  panel of pruritogens (C48/80, endothelin, 5-HT, chloroquine, histamine, lysophosphatidic acid, tryps
57 -HT) in the mammalian brain, and excessive 5-HT signaling is critically implicated in the etiology of
58 s, the major source of 5-HT, and expresses 5-HT receptor subtypes (e.g., 5-HT2C and 5-HT1A) criticall
59  to ZCNT 0.1 NCs as compared to others for 5-HT sensing studies.
60 ) using chitosan as cross-linked agent for 5-HT sensing studies; conducted through cyclic voltammetry
61            Here we report a novel role for 5-HT(2A) in cell-matrix adhesion.In HEK293 cells, which ar
62  demonstrate the existence of a functional 5-HT/5-HT(2B)/AhR axis in human macrophages and indicate t
63 eraction, we developed different MBP-fused 5-HT(3A)-ICD constructs by deleting large segments of its
64 characterized in 5-HT(2A)-, mGlu(2)/Gqo5-, 5-HT(2A)/mGlu(2)-, and 5-HT(2A)/mGlu(2)/Gqo5-expressing HE
65 bited 5-HT-induced currents in heteromeric 5-HT type 3AB receptors (5-HT(3AB)Rs) (IC(50) = 840 and 52
66 ligands targeting the putative heteromeric 5-HT(2A)/mGlu(2) receptor complex, based on the 5-HT(2A) a
67 fects that bupropion exerts on heteromeric 5-HT(3AB) receptors, in particular when constantly present
68 strate that bupropion inhibits heteromeric 5-HT(3AB)Rs as well as homomeric 5-HT(3A)Rs.
69           Serotonin turnover (ratio 5-HIAA/5-HT) was reduced in exposed females and males after 28 da
70  correlation between raphe and hippocampal 5-HT(1A) binding which was more pronounced in HV.
71  IFG and dmPFC correlated with hippocampal 5-HT(1A) binding.
72 teromeric 5-HT(3AB)Rs as well as homomeric 5-HT(3A)Rs.
73 hown to be an antagonist at homopentameric 5-HT type 3A receptors.
74  To date, however, no one has examined how 5-HT influences the dynamics of facial-emotion processing
75             Targeting the serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to potentiat
76 nstrate the existence of a functional 5-HT/5-HT(2B)/AhR axis in human macrophages and indicate that 5
77 the activation and modulation of the human 5-HT(3) type A receptor has been based only on macroscopic
78  only extend our knowledge about the human 5-HT(3)A molecular function but also provide novel insight
79 ding and unbinding of 5-hydroxytryptamine (5-HT) (i.e., serotonin) to the binding pocket located on t
80                       5-hydroxytryptamine (5-HT) is equipped onto nanoparticles (NPs) loaded with pho
81 itters, estimation of 5-hydroxytryptamine (5-HT; Serotonin) release has proved to be challenging.
82 terobivalent ligands were characterized in 5-HT(2A)-, mGlu(2)/Gqo5-, 5-HT(2A)/mGlu(2)-, and 5-HT(2A)/
83  was observed between the two receptors in 5-HT(2A)/mGlu(2) and 5-HT(2A)/mGlu(2)/Gqo5 cells.
84 igands inhibited 5-HT-induced responses in 5-HT(2A)/mGlu(2) cells and both 5-HT- and Glu-induced resp
85 nd both 5-HT- and Glu-induced responses in 5-HT(2A)/mGlu(2)/Gqo5 cells.
86  decreased 5-HT synthesis and/or increased 5-HT reuptake, thereby reducing 5-HT transmission.
87 pathway specifically in EC cells to induce 5-HT secretion.
88 opion with 5-HT dose dependently inhibited 5-HT-induced currents in heteromeric 5-HT type 3AB recepto
89 ties, the seven bivalent ligands inhibited 5-HT-induced responses in 5-HT(2A)/mGlu(2) cells and both
90 ons in the superior raphe, an intermediate 5-HT-ir cell cluster, and an extensive inferior raphe popu
91  intake, genetically predisposed irregular 5-HT receptor density, or change in sensory bombardment ma
92 hat the 5-HT-mediated activation of AhR is 5-HT(2B) dependent because it is abrogated by the 5-HT(2B)
93 rotonin (5-HT) concentrations, and lowered 5-HT GC immunoreactivity.
94                   In addition, three major 5-HT-ir cell groups were identified in the hypothalamus an
95  TSPAN5 can modulate the concentrations of 5-HT and kynurenine.
96              The MPO targeting property of 5-HT modified NPs is confirmed by noninvasive positron emi
97 fers new insights into the organization of 5-HT nuclei in teleosts and provides neuroanatomical evide
98 ies, we present an argument for the use of 5-HT(1A) agonists in the treatment of Dup15q epilepsy.
99 lts indicate that selective stimulation of 5-HT(1A) receptor in the mPFC exerts rapid and sustained a
100  increase in adhesion, while inhibition of 5-HT(2A) by antipsychotics, such as risperidone, olanzapin
101                          The expression of 5-HT(2A)R also augmented intracellular localization of mGl
102 cellular compartments, and coexpression of 5-HT(2A)R with mGluR2 increased the intracellular distribu
103 ude longer than any previous simulation of 5-HT(3A), allow us to observe the dynamic binding and unbi
104 g enough to observe complete activation of 5-HT(3A), the allosteric regulation of ion gating elements
105                          The inhibition of 5-HT(3A)Rs and 5-HT(3AB)Rs was non-use dependent and volta
106        Here we show that preassociation of 5-HT(7) serotonin receptors with G(s) heterotrimers is nec
107 al stress decreased the firing activity of 5-HT(DR->VTA) neurons.
108 that citalopram (which increases levels of 5-HT) caused sustained activation in key limbic regions du
109  dorsal raphe nucleus, the major source of 5-HT, and expresses 5-HT receptor subtypes (e.g., 5-HT2C a
110 be sensed by EC cells, inducing release of 5-HT.
111  results indicate that adiponectin acts on 5-HT neurons through AdipoR1 receptors to regulate depress
112 l secretagogues, drugs acting on opioid or 5-HT receptors, or minimally absorbed antibiotics (all of
113 y which it might be associated with plasma 5-HT concentrations and SSRI clinical response remained un
114                              The presented 5-HT(1A) receptor-biased agonists, preferentially targetin
115 e-neuroendocrine axis in calibrating rapid 5-HT release for intestinal homeostasis.
116 expression and stimulation of human or rat 5-HT(2A) receptor by agonists such as serotonin or 2,5-dim
117 rontal cortex serotonin 5-HT(2A) receptor (5-HT(2A)R) density in the adult offspring, a phenotype pre
118 fects of specific serotoninergic receptor (5-HT(2A)R) stimulation with psilocybin in healthy humans.
119 dition to the serotonin 5-HT(2A) receptor (5-HT(2A)R), the dopamine D(2) receptor (D(2)R) is a key th
120 ng the serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to potentiate endogenous 5-HT t
121             The serotonin type 3 receptor (5-HT(3)) is a ligand-gated ion channel that converts the b
122 elated peptide, and the serotonin receptor 5-HT(3)R.
123  the class A serotonin 5-HT(2A) receptors (5-HT(2A)Rs) affected the localization and trafficking of c
124 ts in heteromeric 5-HT type 3AB receptors (5-HT(3AB)Rs) (IC(50) = 840 and 526 muM, respectively).
125 tion of serotonin (5-HT) type 4 receptors (5-HT(4)Rs) has been shown to have anxiolytic effects in a
126  increased 5-HT reuptake, thereby reducing 5-HT transmission.
127 2 to potentiate the effects of a selective 5-HT(2C)R agonist was established in a drug discrimination
128 f hemodynamics, we implanted serotonergic (5-HT(+)) neuron-enriched embryonic raphe nucleus-derived n
129 , acetylcholine (ACh 10 muM) or serotonin (5-HT 10 muM).
130                   Targeting the serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to pot
131 AN5 were associated with plasma serotonin (5-HT) concentrations which were themselves associated with
132 one, markedly reduced placental serotonin (5-HT) concentrations, and lowered 5-HT GC immunoreactivity
133 ficantly associated with plasma serotonin (5-HT) concentrations, which were themselves associated wit
134  with altered dopamine (DA) and serotonin (5-HT) functioning, the current study aimed to elucidate th
135 amine (DA), uric acid (UA), and serotonin (5-HT) in 0.1 M PBS (pH = 7.4).
136 phe nucleus, the main source of serotonin (5-HT) in the mammalian brain, and excessive 5-HT signaling
137 binding of the neurotransmitter serotonin (5-HT) into a transient cation current that mediates fast e
138                                 Serotonin (5-HT) is a modulator of neural circuitry underlying motor
139 droxylase 2 (TPH2), a marker of serotonin (5-HT) neurons.
140 anslate environmental cues into serotonin (5-HT) production, contributing to intestinal physiology.
141                                 Serotonin (5-HT) represents a quintessential neuromodulator, having b
142           Herein, the efficient serotonin (5-HT) sensing studies have been conducted using the (ZnO N
143 dies indicate that antagonizing serotonin (5-HT) type 3AB (5-HT(3AB)) receptors in brain areas involv
144                   Activation of serotonin (5-HT) type 4 receptors (5-HT(4)Rs) has been shown to have
145 igh affinity and selectivity for serotonin 5-HT(1A) receptors were obtained and tested in four functi
146  up-regulation of frontal cortex serotonin 5-HT(2A) receptor (5-HT(2A)R) density in the adult offspri
147               In addition to the serotonin 5-HT(2A) receptor (5-HT(2A)R), the dopamine D(2) receptor
148 Here, we showed that the class A serotonin 5-HT(2A) receptors (5-HT(2A)Rs) affected the localization
149 ees of conformational change in the setron-5-HT(3A)R structures, throughout the channel and particula
150                                Significant 5-HT-ir innervation was found in components of the vocal p
151                                      Since 5-HT(2A) is associated with many disorders such as dementi
152 amphetamine challenge to evaluate synaptic 5-HT changes in the living human brain.
153 ransmembrane domain (TMD) from synergistic 5-HT binding.
154 modeling-based fMRI analyses revealed that 5-HT depletion altered social reward prediction signals in
155                These results indicate that 5-HT depletion impairs learning from social rewards, on bo
156                    Moreover, we found that 5-HT dose dependently upregulates the expression of AhR ta
157 xis in human macrophages and indicate that 5-HT potentiates the activity of a transcription factor (A
158           Additionally, we have shown that 5-HT(3A)-ICD fused to maltose-binding protein (MBP) direct
159 -chemical properties in correlation to the 5-HT sensing activity.
160 hts into modulation of CeA activity by the 5-HT system and unravels the vulnerability of the CeA 5-HT
161 sults show that intra-mPFC infusion of the 5-HT(1A) receptor agonist 8-OH-DPAT induces rapid and long
162  in the mPFC, and provide evidence for the 5-HT(1A) receptor as a target for the treatment of MDD.
163      Finally, selective stimulation of the 5-HT(1A) receptor increased levels of synaptic proteins an
164 th spatial gene expression patterns of the 5-HT(2A) (5-hydroxytryptamine 2A) and 5-HT(1A) (5-hydroxyt
165 ynthesized monovalent ligands retained the 5-HT(2A) antagonist and mGlu(2) ago-PAM functionalities, t
166 2A)/mGlu(2) receptor complex, based on the 5-HT(2A) antagonist MDL-100,907 and the mGlu(2) ago-PAM JN
167 not understood, although activation of the 5-HT(2A) serotonin receptor (HTR2A) is key.
168 ) dependent because it is abrogated by the 5-HT(2B)-specific antagonist SB204741.
169 sing a simplified model of the pore of the 5-HT(3) receptor (5HT3R) which restrains the backbone stru
170 eterminant for the interaction between the 5-HT(3A)-ICD and RIC-3.
171 entify a 24-amino-acid-long segment of the 5-HT(3A)-ICD as a molecular determinant for the interactio
172  Previously, we have demonstrated that the 5-HT(3A)-ICD is required for the interaction between 5-HT(
173 itoneally) or intra-mPFC infusion with the 5-HT(4)R agonist, RS67333 (0.5 mug/side), were examined in
174 n of AhR target genes in M-MO and that the 5-HT-mediated activation of AhR is 5-HT(2B) dependent beca
175                    In dependent rats, this 5-HT-induced increase of GABA release was attenuated, sugg
176 es exhibit higher sensing activity towards 5-HT in accordance to its higher surface area, lower parti
177 .9 was involved in itch signalling towards 5-HT, C48/80 and SLIGRL.
178 lation in the DR that projects to the VTA (5-HT(DR->VTA) neurons).
179 lating expression of genes associated with 5-HT biosynthesis and metabolism.
180 tion of bupropion or hydroxybupropion with 5-HT dose dependently inhibited 5-HT-induced currents in h
181 he expression of serotonin receptors, with 5-HT(2B) and 5-HT(7) expression restricted to M-CSF-primed
182 oxins were deoxynivalenol-3-glucoside (63%), HT-2 toxin (15%), and tenuazonic acid (13%).
183 e were observed on planar scintigraphy for a HT-1080-FAP-xenotransplanted mouse.
184             Here we demonstrate the use of a HT platform based on desorption electrospray ionization
185                                 In addition, HT attenuated the upregulation of the P2X(3) and increas
186  pressures measured in the first 12 mo after HT.
187 ated that pregnancy should be avoided in all HT recipients, and only 43% (n=52) reported that their c
188 d to HT (123.8 cells/mm(2)) (p = 0.0003) and HT+V (97.5 cells/mm(2)) compared to HT (p = 0.012).
189 sule for HT+M compared to HT (p = 0.001) and HT+V versus HT (p = 0.006).
190 ivalenol, fumonisin B1, zearalanone, T-2 and HT-2 toxin) and emerging mycotoxins (enniatins, beauveri
191 nk P = .018) at 60 months in the A+I arm and HT arm, respectively.
192                                 Under AT and HT, the lipidome was dominated by phosphatidylcholine (P
193 no temporal relationship between bSUVmax and HT.
194 onship between baseline SUVmax (bSUVmax) and HT risk was assessed using cutoff values for SUVmax >10
195               In the presence of MS, DM, and HT, the presence of RSL was at a significantly higher le
196 aled six genetic loci associated with HN and HT above the Bonferroni multiple-test threshold.
197 ion of BMSC-induced hormone independence and HT resistance in anchorage-independent cells revealed di
198 ne on positron emission tomography (PET) and HT risk.
199 o- to threefold higher at HT than at ST, and HT-growth causes an ~19- to 23-fold increase in indel fr
200 de linking of the microelectrode surface and HT-2 toxin antigen binding fragment of antibody (anti-HT
201 is approximately two- to threefold higher at HT than at ST, and HT-growth causes an ~19- to 23-fold i
202        Discordant metabolite effects between HT regimens may partially mediate the differences in CHD
203 xp(B)=1.30, 95% CI 1.10 to 1.56, p<0.01) but HT did not associate with any of the outcomes.
204 Twelve metabolites had discordant effects by HT type and were associated with incident CHD in the WHI
205            Effective compounds identified by HT-DBP induced tumor regression in genetically engineere
206 ropathology, which showed neuroprotection by HT throughout the brain, particularly in females.
207 coelastic moduli and mass of adherent colon (HT-29) and breast cancer (MCF-7) cells from the interpha
208 rative effects on cervical (HeLa) and colon (HT-29) cancer cells.
209                       In addition, compounds HT C1, C2, C4 and C6 inhibited endothelial cell migratio
210  adult mice with reduced DAT expression (DAT-HT) were hypersensitive to short active (SA; 19:5 L:D) p
211                           We then tested DAT-HT mice and WT littermates in psychiatry-relevant behavi
212  present hydroxytyrosol synthetic derivative HT C6 as a new antiangiogenic compound and as a good can
213                             Here, we develop HT-recruit, a pooled assay where protein libraries are r
214 ypic variations and generalizes to different HT image assays.
215 f six synthetic hydroxytyrosyl alkyl ethers (HT C1, C2, C4, C6, C8 and C12).
216 le benefit in rebiopsy of lesions to exclude HT based on SUVmax alone before initiating therapy in pa
217 SUVmax > 10, with 3.3% of these experiencing HT.
218 ll subjects <21 years old who received first HT at Boston Children's Hospital during 1986-2015 with a
219 ejections occurred within 3 months following HT.
220  formal policy regarding pregnancy following HT.
221 rsus HT (p = 0.036) and internal capsule for HT+M compared to HT (p = 0.001) and HT+V versus HT (p =
222 ized protection was seen in white matter for HT+M versus HT (p = 0.036) and internal capsule for HT+M
223 ng approaches for classifying artifacts from HT image data.
224 lets were randomized to: (i) Cooling 1-13 h (HT; n = 6); (ii) HT+ 2.5% ethanol vehicle (HT+V; n = 7);
225  a type of tannin acyl-hydrolase hydrolyzing HTs, CT monomer gallates and depsides - has been reporte
226                              Hydroxytyrosol (HT), which is a polyphenol with a high antioxidant power
227 vel, type 2 diabetes mellitus, hypertension (HT), and metabolic syndrome (MS) were investigated.
228 tional study including grade 1 hypertensive (HT) and normotensive (NT) subjects.
229 zed to: (i) Cooling 1-13 h (HT; n = 6); (ii) HT+ 2.5% ethanol vehicle (HT+V; n = 7); (iii) HT + Melat
230 T+ 2.5% ethanol vehicle (HT+V; n = 7); (iii) HT + Melatonin (HT+M; n = 7).
231 xchangeable phosphate were higher at 48 h in HT+M versus HT (p = 0.036, p = 0.049 respectively).
232 verall TUNEL positive cells were observed in HT+M (47.1 cells/mm(2)) compared to HT (123.8 cells/mm(2
233 ve regulators of innate immune signaling, in HT-29 intestinal epithelial cells challenged with TNF-al
234 terplays with discriminant bacterial taxa in HT and NT subjects highlight the potential role of speci
235 in 2018, these were HT and OF in Lubbock (LU-HT, LU-OF), Overton (OV-HT, OV-OF), Uvalde (UV-HT, UV-OF
236 vehicle (HT+V; n = 7); (iii) HT + Melatonin (HT+M; n = 7).
237                 T-2 and its major metabolite HT-2 toxin are naturally occurring contaminants in cerea
238 ent DOX release profiles in response to mild HT.
239 led release profile in combination with mild HT, which correlated well with their cytotoxicity studie
240                                         Most HT-induced indels are 1-2 bp in size and particularly af
241 ucleosome-free regions, suggesting that much HT-induced mutational damage occurs during cell-cycle ph
242  Furthermore, the antiangiogenic activity of HT C6 was confirmed in vivo in the chick chorioallantoic
243 nmental biomarkers in metastatic biopsies of HT-resistant patients can help refine treatment approach
244 munoenzymatic biosensor for the detection of HT-2 mycotoxin based on carbodiimide linking of the micr
245 ncluding pilot data, examining the effect of HT in the Vannucci model.
246 hanisms leading to the beneficial effects of HT.
247  1:1 ratio to receive three cycles of A+I or HT.
248 8%]) were randomly assigned to either A+I or HT.
249 nd OF in Lubbock (LU-HT, LU-OF), Overton (OV-HT, OV-OF), Uvalde (UV-HT, UV-OF), and Weslaco (WE-HT, W
250  in yeast is a promising tool to overproduce HT at the expense of endogenous tyrosol through central
251 an rejection on protocol biopsy in pediatric HT recipients.
252 ed a retrospective chart review of pediatric HT recipients who had undergone HT between January 2010
253 provides an alternative method of performing HT label-free assays.
254 spital during 1986-2015 with at least 1 post-HT coronary angiogram.
255 riod and decreased to a stable level by post-HT day 90.
256 iac pressures are elevated in the early post-HT period and decrease to levels typical of the native h
257 urements were elevated in the immediate post-HT period and decreased to a stable level by post-HT day
258 MBs, not only during the first 6 months post-HT (1.6% vs. 33.3%, P < .0001), but more so during the 6
259  modality for rejection beyond 6 months post-HT.
260 des and practices surrounding pregnancy post-HT.
261      Neither bSUVmax nor bSUVrange predicted HT in GALLIUM, suggesting that there may be little benef
262 abies immunoglobulin (HRIG; Imogam(R) Rabies-HT), in a ratio of 1:1.
263 ogaea L.) anther lipidome under heat stress (HT) will aid in understanding the mechanisms of heat tol
264 ation, growth at stressful high temperature (HT; 29 degrees C) is highly mutagenic, increasing the mu
265 rker of baseline renal dysfunction, and that HT recipients who develop proteinuria after conversion t
266                         We demonstrated that HT attenuates the enhancement of the BP response induced
267  cancer patients, our data demonstrated that HT-DBP could be used to generate personalized pharmacoty
268                                          The HT regimens were as follows: trabectedin in HG-MLPS; gem
269                                          The HT-2 toxin and anti-HT2 (10) Fab reaction was reported b
270 the range of intracardiac pressures in these HT patients is important for the clinical interpretation
271                                      In this HT-LC-HRMS approach, raw spectra of the peaks eluting fr
272                 Image-based high throughput (HT) screening provides a rich source of information on d
273                                        Thus, HT-DBP appears to be an ex vivo functional method with s
274 erved in HT+M (47.1 cells/mm(2)) compared to HT (123.8 cells/mm(2)) (p = 0.0003) and HT+V (97.5 cells
275 6) and internal capsule for HT+M compared to HT (p = 0.001) and HT+V versus HT (p = 0.006).
276 003) and HT+V (97.5 cells/mm(2)) compared to HT (p = 0.012).
277 d competition experiments on FAP-transfected HT-1080 (HT-1080-FAP) or on mouse FAP-expressing (HEK-mu
278 ma (FL) undergo histological transformation (HT).
279 ic assessment in pediatric heart transplant (HT) patients, expected intracardiac pressure measurement
280       We report 2 cases of heart transplant (HT) recipients with COVID-19.
281 lopathy (CAV) in pediatric heart transplant (HT) recipients.
282       Pregnancy after heart transplantation (HT) is a concern for many female recipients.
283  was performed to examine if heat treatment (HT) has beneficial effects on the exaggerated exercise p
284       Testing environments were high tunnel (HT) and open-field (OF) in Uvalde in 2017 while in 2018,
285 ts 18:2 fatty acids to 18:3) decreased under HT for the heat-tolerant genotype SPT 06-07 but not for
286 of pediatric HT recipients who had undergone HT between January 2010 and December 2015 at Lucile Pack
287  (1.4%) patients with bSUVmax > 20 underwent HT.
288 , LU-OF), Overton (OV-HT, OV-OF), Uvalde (UV-HT, UV-OF), and Weslaco (WE-HT, WE-OF).
289  (HT; n = 6); (ii) HT+ 2.5% ethanol vehicle (HT+V; n = 7); (iii) HT + Melatonin (HT+M; n = 7).
290 ion was seen in white matter for HT+M versus HT (p = 0.036) and internal capsule for HT+M compared to
291 phosphate were higher at 48 h in HT+M versus HT (p = 0.036, p = 0.049 respectively).
292 M compared to HT (p = 0.001) and HT+V versus HT (p = 0.006).
293 -OF), Uvalde (UV-HT, UV-OF), and Weslaco (WE-HT, WE-OF).
294  in Uvalde in 2017 while in 2018, these were HT and OF in Lubbock (LU-HT, LU-OF), Overton (OV-HT, OV-
295 he differences in CHD risk between the 2 WHI-HT trials.
296 ssion status were 24.4% (WHI-OS), 25.7% (WHI-HT), and 44.7% (NHSII-MBS).
297                                   In the WHI-HT trials (Women's Health Initiative Hormone Therapy), t
298 ed among 1295 WHI Hormone Therapy Trial (WHI-HT) participants.
299                                        While HT significantly reduced BS-binding efficiency despite n
300       The first is a 59-year-old female with HT in 2012 who presented on March 20, 2020 with fever, h

 
Page Top